Oruka Therapeutics stock initiated with Buy rating at UBS on cancer drug potential

1 day ago 4
Read Entire Article
  1. Homepage
  2. Finance
  3. Oruka Therapeutics stock initiated with Buy rating at UBS on cancer drug potential

Related

ING sees muted eurozone growth despite low unemployment

ING sees muted eurozone growth despite low unemployment

17 minutes ago 0
Bread Financial stock initiated with Buy rating at UBS, $92 price target

Bread Financial stock initiated with Buy rating at UBS, $92 ...

17 minutes ago 0
Zalando shares fall as company announces closure of German fulfillment center

Zalando shares fall as company announces closure of German f...

17 minutes ago 0

Trending

1. detroit news
2. wral
3. washoe county school district
4. memphis weather
5. daily horoscope
6. jacksonville weather
7. austin weather
8. flu a symptoms
9. brisbane international
10. dallas weather

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

11 months ago 659
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

9 months ago 521
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

10 months ago 385
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

10 months ago 349
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

1 year ago 336
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2026. All rights are reserved